Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introduction: patients who have suffered a Cerebral Infarction (stroke) are not only concerned about the consequences of it; the patient, family and doctors are concerned about the possibility that the disease will recur. The correlation between risk factors and recurrence of cerebral infarction is not entirely clear. The objective of this work is to establish the rate of recurrence of cerebral infarction during the first year after the first ischemic event in patients hospitalized in the Neurology Ward of the Carlos Andrade Marín Hospital, the mortality rate and risk factors related to it. Materials and methods: an observational study was performed, where electronic medical records (Information System AS 400) of 80 patients who suffered a Cerebral infarction, verified by imaging studies between january and december 2011 and who were subsequently periodically evaluated within 1 year, were analyzed. All patients were receiving medication for stroke prevention. Results: the study showed that 9 patients (11%) had recurrence and among these 4 died. All patients who died had Atrial Fibrillation Cardio Embolism as a cause of their first cerebral infarction. Conclusion: recurrence is directly related to patient age and the presence of hypertension as a risk factor.
REFERENCIAS BIBLIOGRÁFICAS
Jones VN. The Forgotten Survivor. Stroke Smart (electronic version). May 2006. Disponible en www.stroke.org/site/ PageServer/MAG (Tomado el 01 de octubre de 2013)
Brott T, Bogausslavsky J. Treatment of Acute Isckemic Stroke.
N Engl J Med, 2000; 343(10):710- 22
Giacalone G, Abbas M, Corea F. Prevention Strategies for Cardioembolic Stroke: Present and Future Perspectives. Open Neurology J, 2010; 4:56-63
Moroney J, Bagiella E, Paik MC, et al. Risk Factors for Early Recurrence After Ischemic Stroke The Role of Stroke Syndrome and Subtype. Stroke, 1998; 29:2118-2124
Judd SE, Kleindorfer DO, McClure LA, et al. Self-Report of Stroke, Transient Ischemic Attack, or Stroke Symptoms and Risk of Future. Stroke in the Reasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Stroke, 2013; 44:55-60
Townend E, Tinson D, Kwan J, Sharpe M. Fear of recurrence and beliefs about preventing recurrence in persons who have suffered a stroke. J Psychosom Res, 2006; 61(6):747-55
Appelros P, Nydevik I, Vittanen M. Poor outcome after first ever stroke whitin the first year. Stroke, 2003; 34:122-126
Sprigg N, Gray LJ, Bath PM, Lindenstrom E, Boysen G, De Deyn PP, et al. Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). J Neurol Sci, 2007; 254(1-2):54-9
Straus SE, Majumdar SR, Mc Alister FA. New evidence for stroke prevention: Scientific review. JAMA, 2002; 288:1388-1395
Burn J, Dennis M, Bamdford J, Sandercock P, Wade D, Warlow C. Long term risk of recurrent stroke after a first ever stroke. The Oxforshire Community Stroke Project. Stroke, 1994; 25:333-7
Kiely DK, Wolf PA, Cupples LA, Beiser AS, Myers RH.
Familial aggregation of stroke: the Framingham study. Stroke, 1993, 24:1366-71
Vickrey BG, Rector TS, Wickstrom SL. et al. Occurrence of secondary ischemic events among persons whit atherosclerotic disease. Stroke, 2002; 33:901-906
Lai SL, Weng HH, Lee M, Hsiao MC, Lin LJ, Huang WY. Risk factors and subtype analysis of acute ischemic stroke. Eur Neurol, 2008; 60(5):230-236
Bang OY, Saver JL, Liebeskind DS, Pineda S, Ovbiagele B. Association of serum lipids indices with large artery atherosclerotic stroke. Neurology, 2008; (11):841-7
Laloux P, Galanti L, Jamart J. Lipids in ischemic stroke subtypes.
Acta Neurol Belg, 2004; (1):913
Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C.
Ten year risk of first recurrence stroke after a first ever stroke in the Perth Community Stroke Study. Stroke, 2004; 35:731-735
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.